Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
2016 · Circulation · 1,912 citations
https://doi.org/10.1161/circulationaha.116.021612
C
Candida Cristina Quarta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
110
Papers
10.5K
Citations
39
h-index
48
i10-index
Candida Cristina Quarta is an academic researcher from Alexion Pharmaceuticals (United States). The author has contributed to research in topics: Amyloidosis: Diagnosis, Treatment, Outcomes & Parathyroid Disorders and Treatments & Peptidase Inhibition and Analysis. The author has an h-index of 39, co-authored 94 publications.
ORCID: 0000-0003-0935-2873Papers by this author
worksSystemic Cardiac Amyloidoses
2009 · Circulation · 760 citations
https://doi.org/10.1161/circulationaha.108.843334
A new staging system for cardiac transthyretin amyloidosis
2017 · European Heart Journal · 704 citations
https://doi.org/10.1093/eurheartj/ehx589
Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis
2014 · JACC Heart Failure · 236 citations
https://doi.org/10.1016/j.jchf.2014.03.009
Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
2017 · European Heart Journal · 217 citations
https://doi.org/10.1093/eurheartj/ehx047
Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping
2023 · JACC. Cardiovascular imaging · 33 citations
https://doi.org/10.1016/j.jcmg.2023.02.019
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat